Literature DB >> 12539045

Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors.

Wen Yong Chen1, Xiaobei Zeng, Mark G Carter, Craig N Morrell, Ray-Whay Chiu Yen, Manel Esteller, D Neil Watkins, James G Herman, Joseph L Mankowski, Stephen B Baylin.   

Abstract

The gene hypermethylated in cancer-1 (HIC1) encodes a zinc-finger transcription factor that belongs to a group of proteins known as the POZ family. HIC1 is hypermethylated and transcriptionally silent in several types of human cancer. Homozygous disruption of Hic1 impairs development and results in embryonic and perinatal lethality in mice. Here we show that mice disrupted in the germ line for only one allele of Hic1 develop many different spontaneous malignant tumors, including a predominance of epithelial cancers in males and lymphomas and sarcomas in females. The complete loss of Hic1 function in the heterozygous mice seems to involve dense methylation of the promoter of the remaining wild-type allele. We conclude that HIC1 is a candidate tumor-suppressor gene for which loss of function in both mouse and human cancers is associated only with epigenetic modifications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12539045     DOI: 10.1038/ng1077

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  68 in total

Review 1.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

Review 2.  Miller-Dieker syndrome: analysis of a human contiguous gene syndrome in the mouse.

Authors:  Jessica Yingling; Kazuhito Toyo-Oka; Anthony Wynshaw-Boris
Journal:  Am J Hum Genet       Date:  2003-08-05       Impact factor: 11.025

Review 3.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.

Authors:  Sung-Uk Lee; Takahiro Maeda
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

Review 4.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

5.  Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.

Authors:  Capucine Van Rechem; Gaylor Boulay; Sébastien Pinte; Nicolas Stankovic-Valentin; Cateline Guérardel; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

Review 6.  Promoter hypermethylation in prostate cancer.

Authors:  Jong Y Park
Journal:  Cancer Control       Date:  2010-10       Impact factor: 3.302

7.  Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice.

Authors:  Vijayalakshmi Nandakumar; Mudit Vaid; Trygve O Tollefsbol; Santosh K Katiyar
Journal:  Carcinogenesis       Date:  2010-12-24       Impact factor: 4.944

8.  How epigenetics integrates nuclear functions. Workshop on epigenetics and chromatin: transcriptional regulation and beyond.

Authors:  Manel Esteller; Geneviève Almouzni
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

Review 9.  Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.

Authors:  Oliver Galm; Manel Esteller
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

10.  Developmentally programmed 3' CpG island methylation confers tissue- and cell-type-specific transcriptional activation.

Authors:  Da-Hai Yu; Carol Ware; Robert A Waterland; Jiexin Zhang; Miao-Hsueh Chen; Manasi Gadkari; Govindarajan Kunde-Ramamoorthy; Lagina M Nosavanh; Lanlan Shen
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.